Trifluridine (Lonsurf Figure 1)
Chemical structure diagram of trifluridine, one of the active ingredients in LONSURF (trifluridine and tipiracil) tablets.*
Lonsurf Tablet, Film Coated
Product Images NDC 64842-1020
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lonsurf (NDC 64842-1020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Taiho Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
20 mg Tablet 20-count Bottle (Lonsurf Figure 10)
LONSURF 20 mg/8.19 mg film-coated tablets packaging label shows the NDC 64842-1020-1 and indicates a bottle containing 20 tablets. The label lists the active ingredients trifluridine 20 mg and tipiracil 8.19 mg per tablet. It includes manufacturer information for Taiho Pharmaceutical Co., Ltd., Japan, and Taiho Oncology, Inc., Princeton, NJ, USA. Additional details such as storage instructions and a barcode are visible.*
20 mg Tablet-20 Count Carton (Lonsurf Figure 11)
The image shows a flat carton label for Lonsurf 20 mg/8.19 mg film-coated tablets, an oral prescription drug containing trifluridine and tipiracil. The label includes dosing instructions, storage conditions, and manufacturer information from Taiho Pharmaceutical Co., Ltd. The package contains 20 tablets.*
20 mg Tablet 40-count Bottle (Lonsurf Figure 12)
LONSURF (trifluridine and tipiracil) tablets with strength 20 mg/8.19 mg, in film-coated oral dosage form. The label indicates a package size of 40 tablets. It includes the NDC number 64842-1020-2 and states the product is Rx only. Manufacturer listed is Taiho Pharmaceutical Co., Ltd., Japan, with a manufacturing location in Princeton, NJ. The label also contains storage instructions, a barcode, and a QR code.*
20 mg Tablet-40 Count Carton (Lonsurf Figure 13)
LONSURF 20 mg/8.19 mg film-coated tablets packaging label for oral administration. Contains active ingredients trifluridine and tipiracil. The label includes dosage strength, 40 tablets per package, and manufacturer information for Taiho Pharmaceutical Co., Ltd. Storage instructions and a barcode are also visible.*
20 mg Tablet 60-count Bottle (Lonsurf Figure 14)
Lonsurf (trifluridine and tipiracil) tablets film coated, 20 mg/8.19 mg strength, packaged as 60 tablets. The label includes manufacturer Taiho Pharmaceutical Co., Ltd., Japan and Taiho Oncology, Inc., Princeton, NJ, USA. The label displays storage instructions and dosage information referencing prescribing information, with lot and expiration date fields.*
20 mg Tablet-60 Count Carton (Lonsurf Figure 15)
LONSURF 20 mg/8.19 mg film-coated tablets packaging label showing the proprietary name, active ingredients (trifluridine and tipiracil), dosage strength, and oral administration route. The label indicates a count of 60 tablets, manufacturer Taiho Pharmaceutical Co., Ltd., and storage instructions. The NDC number 64842-1020-3 and barcode are also visible.*
Figure 2 (Lonsurf Figure 16)
A Kaplan-Meier survival curve graph comparing overall survival percentage over time in months between patients treated with trifluridine and tipiracil versus placebo. The solid line represents trifluridine and tipiracil, while the dashed line represents placebo. The graph includes the number of patients at risk for each group at multiple time points up to 25 months.*
Tipiracil Hydrochloride (Lonsurf Figure 2)
Chemical structure diagram showing the molecular structure of the active ingredient trifluridine, including chlorine and hydrogen chloride components as part of the compound.*
Figure 1 (Lonsurf Figure 3)
A survival probability plot comparing LONSURF (trifluridine and tipiracil) with placebo over 20 months from randomization. The x-axis shows months, and the y-axis shows survival probability percentage. The graph includes risk tables for both LONSURF and placebo groups across the timeline.*
15 mg Tablet 20-count Bottle (Lonsurf Figure 4)
LONSURF tablets label showing the proprietary name with active ingredients trifluridine and tipiracil. The strength is 15 mg trifluridine and 6.14 mg tipiracil per tablet. The package contains 20 film-coated oral tablets. Labeler is Taiho Pharmaceutical Co., Ltd., manufactured in Japan and for Taiho Oncology, Inc. in the USA. Includes storage information and barcodes.*
15mg Tablet-20 Count Carton (Lonsurf Figure 5)
LONSURF 15 mg/6.14 mg film-coated tablets carton label for oral administration, containing 20 tablets. Active ingredients are trifluridine and tipiracil. Label shows NDC 64842-1025-1 and indicates the product is manufactured by Taiho Pharmaceutical Co., Ltd. The label includes storage instructions and a barcode area.*
15 mg Tablet 40-count Bottle (Lonsurf Figure 6)
Label for Lonsurf tablets containing 15 mg trifluridine and 6.14 mg tipiracil. The label indicates a package of 40 film-coated oral tablets by Taiho Pharmaceutical Co., Ltd. It includes dosage information, storage instructions at 20° to 25°C with permitted excursions, and manufacturer details for Taiho Oncology, Inc.*
15mg Tablet-40 Count Carton (Lonsurf Figure 7)
Lonsurf 15 mg/6.14 mg film-coated tablets carton label showing the proprietary name Lonsurf and generic ingredients trifluridine and tipiracil. The label indicates oral administration and contains 40 tablets. Manufacturer is Taiho Pharmaceutical Co., Ltd., Japan, with manufacturing for Taiho Oncology, Inc., Princeton, NJ 08540 USA. Storage instructions and a barcode are also visible.*
15 mg Tablet 60-count Bottle (Lonsurf Figure 8)
LONSURF 15 mg/6.14 mg film-coated tablets packaging label showing 60 tablets per container. The label displays the active ingredients trifluridine and tipiracil, with the respective amounts per tablet. Manufactured by Taiho Pharmaceutical Co., Ltd., Japan, for Taiho Oncology, Inc. The label includes storage instructions and drug lot and expiration details.*
15 mg Tablet-60 Count Carton (Lonsurf Figure 9)
Carton label for Lonsurf (trifluridine and tipiracil) tablets, film-coated, oral administration. Strength specified as 15 mg/6.14 mg per tablet. Package contains 60 tablets. Label includes dosage information, storage instructions, manufacturer details (Taiho Pharmaceutical Co., Ltd., Japan), and NDC 64842-1025-3. Features the Lonsurf logo and highlights that the product is for prescription use only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
